Article
Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.
Brain pathology (Zurich, Switzerland) - 1 Sept 2026
Go Kohichi, Katsuma Asako, Yoshioka Ema, Shofuda Tomoko, Fukuoka Kohei, Ichimura Koichi, Matsushita Yuko, Mineharu Yohei, Makino Yasuhide, Kawauchi Takeshi, Sasaki Atsushi, Hirato Junko, Inoue Takeshi, Kodama Yoshinori, Mano Masayuki, Kanematsu Daisuke, Kijima Noriyuki, Kagawa Naoki, Keino Dai, Mukasa Akitake, Suzuki Tomonari, Yoshimoto Koji, Kuga Daisuke, Horiguchi Keishi, Yamaguchi Shigeru, Kanamori Masayuki, Yamasaki Kai, Ishibashi Kenichi, Akai Takuya, Yamaoka Masayoshi, Ishizaki Ryuji, Kawamura Atsufumi, Ohba Shigeo, Ishida Joji, Ando Ryo, Fukai Junya, Miwa Tomoru, Fujii Masazumi, Muroi Ai, Saito Kuniaki, Harada Atsuko, Hayashi Yasuhiko, Nonaka Masahiro, Park Young-Soo, Kobayashi Yusuke, Higuchi Tadashi, Miyairi Yosuke, Yoshifuji Kazuhisa, Takebe Noriyoshi, Oya Soichi, Nakajo Kosuke, Nakada Mitsutoshi, Nakano Yoshiteru, Kambara Mizuki, Adachi Koji, Tanaka Kazuhiro, Nakamura Hideo, Sonoda Yukihiko, Saito Ryuta, Wataya Takafumi, Kurozumi Kazuhiko, Taylor Michael D, Narita Yoshitaka, Shibui Soichiro, Arai Hajime, Sakamoto Hiroaki, Date Isao, Nagane Motoo, Nishikawa Ryo, Arakawa Yoshiki, Kanemura Yonehiro
Abstract excerpt
Medulloblastoma (MB) is a biologically and clinically heterogeneous pediatric brain tumor. However, large-scale molecular subgrouping studies have mainly been conducted in Western populations, and comprehensive data from Asia are limited. To address this gap, we analyzed 242 MB cases collected from 39 institutions through the Japan Pediatric Molecular Neuro-Oncology Group, performing centralized molecular...
Read the complete abstract on PubMed